Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab.
about
Gene Expression Analysis of the 26S Proteasome Subunit PSMB4 Reveals Significant Upregulation, Different Expression and Association with Proliferation in Human Pulmonary Neuroendocrine TumoursRadioimmunoconjugates for treating cancer: recent advances and current opportunities.Whither Radioimmunotherapy: To Be or Not To Be?
P2860
Phase 1 study of radiosensitization using bortezomib in patients with relapsed non-Hodgkin lymphoma receiving radioimmunotherapy with 131I-tositumomab.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Phase 1 study of radiosensitiz ...... therapy with 131I-tositumomab.
@ast
Phase 1 study of radiosensitiz ...... therapy with 131I-tositumomab.
@en
type
label
Phase 1 study of radiosensitiz ...... therapy with 131I-tositumomab.
@ast
Phase 1 study of radiosensitiz ...... therapy with 131I-tositumomab.
@en
prefLabel
Phase 1 study of radiosensitiz ...... therapy with 131I-tositumomab.
@ast
Phase 1 study of radiosensitiz ...... therapy with 131I-tositumomab.
@en
P2093
P2860
P1433
P1476
Phase 1 study of radiosensitiz ...... therapy with 131I-tositumomab.
@en
P2093
Anca Avram
Daniel Lebovic
Erica Chapman
John P Leonard
June Greenberg
Kent Griffith
Madhu Mazumdar
Mark S Kaminski
Morton Coleman
P2860
P304
P356
10.3109/10428194.2014.914195
P577
2014-06-17T00:00:00Z